英文别名 |
(3R,5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-Trimethyldecahydro-3H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-ol;(3r,5as,6r,8as,9r,10r,12r,12ar)-decahydro-3,6,9-trimethyl-3,12-epoxy-12h-pyrano[4,3-j]-1,2-benzodioxepin-10-ol;(3r,5as,6r,8as,9r,10s,12r,12ar)-decahydro-3,6,9-trimethyl-3,12-epoxy-12h-pyrano[4,3-j]-1,2-benzodioxepin-10-ol;Dihydroarteminisin;Dihydroartemisin;Alaxin;b-Dihydroartemisinin;Cotecxin;Dihydro Artemisinin;Dihydroartemisinin,mixture of α and β isomers;(3R,5aS,6R,8aS,9R,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-ol;(3R,5aS,6R,8aS,9R,12S,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-ol;Cotexin;DHA;DHQHS 2;Dihydroginghaosu;Dihydroqinghaosu;dihydroquinghaosu;dihyhydroartemisinin;Salaxin;β-Dihydroartemisinin;(3R,5aS,6R,8aS,9R,12R,12aR)-Decahydro-10-hydroxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin;Dihydroartemisinin;BN0685;(1S,5R,9R,12R,13R)-1,5,9-Trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol;Dihydro Artemisinin (a,? Mixture);BBL033188;STL146329;SY058680;A916373;Q5276420;Artenimol;6A9O50735X;81496-82-4;DIHYDROARTEMISININ [MI];DIHYDROARTEMISININ [WHO-DD];DTXSID501021652;FT-0649320;(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecan-10-ol;Dihydroartemisinin, .beta.-;.beta.-dihydroartemisinin;ARTENIMOLUM [WHO-IP LATIN];(3R,5AS,6R,8AS,9R,10S,12R,12AR)-3,6,9-TRIMETHYLDECAHYDRO-3,12-EPOXY-12H-PYRANO(4,3-J)-1,2-BENZODIOXEPIN-10-OL;Santecxin;GNF-PF-5634;HY-N0176;AKOS032949625;ARTENIMOL [WHO-IP];Dynamax;DIHYDROARTEMISININ [USP-RS];Di-hydroqinghaosu;EURARTESIM COMPONENT DIHYDROARTEMISININ;(3R,5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-12H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-ol;71939-50-9;3,12-Epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-ol, decahydro-3,6,9-trimethyl-, (3R,5aS,6R,8aS,9R,10S,12R,12aR)-;3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-ol, decahydro-3,6,9-trimethyl-, (3R,5aS,6R,8aS,9R,10S,12R,12aR)-;ARTENIMOL [MART.];CS-5595;BRD-K62213621-001-01-6;(3r,5as,6r,8as,9r,10s,12r,12ar)-decahydro-3,6,9-trimethyl-3,12-epoxy-12h-pyrano[4,3-j][1,2]benzodioxepin-10-ol;Dihydroartemisinine;GTPL9957;SCHEMBL17156483;CHEBI:135921;NS00071253;ARTENIMOL [WHO-DD];EN300-7419972;Artenimol [INN];(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-TRIMETHYL-11,14,15,16-TETRAOXATETRACYCLO[10.3.1.0?,(1)(3).0?,(1)(3)]HEXADECAN-10-OL;Artenimol (INN);DIHYDROARTEMISININ, BETA-;NSC 758682;A11600;artemisinin, dihydro-;P01BE05;98%,mixture of ;dehydroartemisin;Artemisinin, dihydro;3,12-Epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-ol, decahydro-3,6,9-trimethyl-, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12beta,12aR*))-;BJDCWCLMFKKGEE-ISOSDAIHSA-N;UNII-6A9O50735X;(3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodio... |